19092-Solid Tumors-NA-1384

Solid Tumors

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number:

  • Address

1441 N Beckley Ave, Suite 102
Dallas, TX 75203
P: (214) 943-9911

Search by practice name, trial titles, indicators and specific disease types.